XBiotech Inc.

NASDAQ: XBIT · Real-Time Price · USD
3.20
0.00 (0.00%)
At close: Aug 22, 2025, 3:59 PM
3.26
1.87%
After-hours: Aug 22, 2025, 04:43 PM EDT

XBiotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a 2.62M 2.62M 2.62M 2.62M 300K 1.98M 3.51M 4.01M 8.21M 11.05M 14.04M 18.39M 19.16M 25.19M 36.17M
Cost of Revenue
1.32M 881K 439K 873K 866K 1.3M 1.74M 1.33M 1.11M 881K 651K 1.68M 2.58M 3.73M 5.82M 7.02M 15.34M 27.18M
Gross Profit
-1.32M -881K -439K 1.75M 1.75M 1.32M 876K -1.03M 871K 2.63M 3.36M 6.53M 8.47M 10.31M 12.57M 12.14M 9.86M 8.99M
Operating Income
-36.54M -45.17M -42.47M -42.31M -42.93M -41.22M -37.51M -37.09M -34.95M -33.79M -34.49M -33.52M -30.86M -29.38M -25.08M -22.81M -23.75M -19.66M
Interest Income
7.5M 8.66M 9.81M 10.32M 10.48M 10.3M 10.42M 10.29M 8.77M 6.5M 3.82M 1.46M 577K 459K 467K 485K 484K 667K
Pretax Income
-28.14M -39.44M -38.56M -32.75M -34.8M -30.44M -24.31M -22.2M -25.41M -30.99M -33.59M -38.63M -33.43M -28.87M -25.46M -19.88M -18.02M -15.51M
Net Income
-28.16M -39.41M -38.53M -32.66M -35.01M -30.74M -24.56M -23.13M -28.42M -31.32M -32.9M -36.16M -26.77M -20.24M -17.41M -12.79M -12.05M -13.78M
Selling & General & Admin
4.63M 5.62M 4.28M 3.7M 3.9M 3.91M 4.23M 5.01M 4.88M 5.91M 6.31M 7.04M 7.74M 9.24M 9.39M 12M 13.91M 15.64M
Research & Development
31.9M 39.55M 37.76M 37.74M 38.16M 36.44M 32.85M 32.36M 31.83M 30.95M 31.54M 33.01M 31.59M 30.45M 28.27M 22.95M 19.7M 13.01M
Other Expenses
n/a n/a -200K -197K -197K 553K 883K 878K 878K 9K -121K -119K -119K -2K -12K -12K -12K -10K
Operating Expenses
36.54M 45.17M 42.04M 41.44M 42.06M 40.35M 37.08M 37.37M 36.7M 36.86M 37.85M 40.05M 39.34M 39.69M 37.66M 34.95M 33.6M 28.65M
Interest Expense
495K 495K 407K 203K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a -432K -866K -866K -866K -434K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
36.54M 45.17M 42.47M 42.31M 42.93M 41.22M 37.51M 37.38M 36.93M 37.3M 38.5M 41.73M 41.91M 43.42M 43.48M 41.97M 48.94M 55.83M
Income Tax Expense
25K -28K -32K -90K 209K 305K 243K 920K 3.01M 334K -688K -2.47M -6.66M -8.63M -8.04M -7.1M -5.97M -1.73M
Shares Outstanding (Basic)
30.49M 30.49M 30.46M 30.47M 30.46M 30.44M 30.44M 30.44M 30.44M 30.44M 30.44M 30.44M 30.44M 30.04M 30.34M 30.34M 29.99M 29.42M
Shares Outstanding (Diluted)
30.49M 30.49M 30.46M 30.47M 30.46M 30.44M 30.44M 30.44M 30.44M 30.44M 30.44M 30.44M 30.44M 30.04M 30.34M 30.34M 29.99M 29.42M
EPS (Basic)
-0.92 -1.29 -1.26 -1.07 -1.15 -1.01 -0.81 -0.77 -0.95 -1.04 -1.09 -1.19 -0.88 -0.67 -0.58 -0.43 -0.41 -0.48
EPS (Diluted)
-0.92 -1.29 -1.26 -1.07 -1.15 -1.01 -0.81 -0.77 -0.95 -1.04 -1.09 -1.19 -0.88 -0.67 -0.58 -0.43 -0.41 -0.48
EBITDA
-25.88M -39.13M -39.22M -37.47M -41.19M -39.48M -35.77M -35.33M -32.9M -31.44M -31.88M -30.65M -28.04M -26.64M -22.43M -20.28M -21.36M -17.36M
EBIT
-27.64M -40.88M -40.97M -39.21M -42.93M -41.22M -37.51M -37.09M -34.95M -33.79M -34.49M -33.52M -30.86M -29.38M -25.08M -22.81M -23.75M -19.66M
Depreciation & Amortization
1.76M 1.75M 1.75M 1.74M 1.73M 1.73M 1.74M 1.75M 2.06M 2.35M 2.61M 2.87M 2.83M 2.74M 2.65M 2.53M 2.39M 2.3M